Total Payments
$135.39
2023 Payments
$15.11
Companies
6
Transactions
8
Medicare Patients
8,732
Medicare Billing
$616,192
Payment Breakdown by Category
Food & Beverage$135.39 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $135.39 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $31.83 | 2 | $0 (2022) |
| Abbott Laboratories | $28.53 | 2 | $0 (2023) |
| ZS Pharma. Inc. | $24.16 | 1 | $0 (2017) |
| Ethicon US, LLC | $20.23 | 1 | $0 (2018) |
| EKOS Corporation | $19.47 | 1 | $0 (2019) |
| Amgen Inc. | $11.17 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $15.11 | 1 | Abbott Laboratories ($15.11) |
| 2022 | $31.83 | 2 | PFIZER INC. ($31.83) |
| 2021 | $13.42 | 1 | Abbott Laboratories ($13.42) |
| 2019 | $19.47 | 1 | EKOS Corporation ($19.47) |
| 2018 | $20.23 | 1 | Ethicon US, LLC ($20.23) |
| 2017 | $35.33 | 2 | ZS Pharma. Inc. ($24.16) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Neuromodulation | ||||||
| 10/24/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/08/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/23/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Neuromodulation | ||||||
| 08/12/2019 | EKOS Corporation | EKOSONIC (Device) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: PERIPHERAL VASCULAR | ||||||
| 02/21/2018 | Ethicon US, LLC | LINX Reflux Management System (Device) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Endo-Mechanical | ||||||
| 09/13/2017 | ZS Pharma. Inc. | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/14/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,979 | 3,402 | $273,174 | $165,139 |
| 2022 | 21 | 2,088 | 3,409 | $269,047 | $151,614 |
| 2021 | 24 | 2,264 | 3,817 | $281,725 | $156,518 |
| 2020 | 23 | 2,401 | 4,043 | $291,353 | $142,921 |
Total Patients
8,732
Total Services
14,671
Medicare Billing
$616,192
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 330 | 662 | $94,004 | $54,733 | 58.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 271 | 271 | $42,818 | $33,555 | 78.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 265 | 377 | $33,930 | $21,848 | 64.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 160 | 160 | $24,480 | $12,130 | 49.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 70 | $13,860 | $8,225 | 59.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 400 | 963 | $15,408 | $8,019 | 52.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 34 | 35 | $11,025 | $7,181 | 65.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 177 | 177 | $4,602 | $4,510 | 98.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 22 | 22 | $5,192 | $3,490 | 67.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 23 | 23 | $5,129 | $3,367 | 65.6% |
| 85610 | Blood test, clotting time | Office | 2023 | 40 | 410 | $10,250 | $1,722 | 16.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 36 | 39 | $1,638 | $1,581 | 96.5% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $1,210 | $1,186 | 98.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 23 | 23 | $1,610 | $834.88 | 51.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 55 | 73 | $4,380 | $701.44 | 16.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 17 | 17 | $782.00 | $569.33 | 72.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $546.00 | $535.08 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 18 | $1,170 | $483.16 | 41.3% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 25 | 30 | $1,140 | $468.00 | 41.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 346 | 616 | $87,472 | $48,649 | 55.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 258 | 258 | $40,764 | $31,936 | 78.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 290 | 400 | $36,000 | $20,693 | 57.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 189 | 191 | $29,223 | $13,395 | 45.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 40 | 47 | $9,306 | $5,916 | 63.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 25 | 28 | $8,820 | $5,526 | 62.7% |
About Dr. John Holman, M.D
Dr. John Holman, M.D is a Infectious Disease healthcare provider based in Greenwood, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922095405.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Holman, M.D has received a total of $135.39 in payments from pharmaceutical and medical device companies, with $15.11 received in 2023. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($135.39).
As a Medicare-enrolled provider, Holman has provided services to 8,732 Medicare beneficiaries, totaling 14,671 services with total Medicare billing of $616,192. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Internal Medicine
- Location Greenwood, SC
- Active Since 09/30/2005
- Last Updated 12/09/2021
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1922095405
Products in Payments
- ELIQUIS (Drug) $31.83
- BRILINTA (Drug) $24.16
- LINX Reflux Management System (Device) $20.23
- EKOSONIC (Device) $19.47
- PROCLAIM (Device) $15.11
- Proclaim IPG (Device) $13.42
- Prolia (Biological) $11.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.